Amgen (AMGN) Finished Goods (2013 - 2017)

Amgen (AMGN) has reported Finished Goods for 5 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2017.

• In Q2 2017, Finished Goods changed N/A year-over-year to $1.1 billion; the TTM figure through Jun 2017 stood at $1.1 billion (changed N/A YoY), while the FY2016 annual figure was $912.0 million, up 29.36% from the prior year.
• Finished Goods came in at $1.1 billion for Q2 2017 at Amgen, down from $1.2 billion in the prior quarter.
• The five-year high for Finished Goods was $1.2 billion in Q1 2017, with the low at $705.0 million in Q4 2015.
• Average Finished Goods over 5 years is $920.5 million, with a median of $914.0 million recorded in 2014.
• Across the five-year window, Finished Goods fell 21.49% in 2015 and jumped 48.02% in 2017, its largest moves.
• Year by year, Finished Goods stood at $738.0 million in 2013, then increased by 21.68% to $898.0 million in 2014, then retreated by 21.49% to $705.0 million in 2015, then increased by 29.36% to $912.0 million in 2016, then climbed by 21.27% to $1.1 billion in 2017.
• According to Business Quant data, Finished Goods over the past three periods registered $1.1 billion, $1.2 billion, and $912.0 million for Q2 2017, Q1 2017, and Q4 2016 respectively.